Greenphire Selected as a PACT Enterprise Award Finalist

Printer-friendly versionPDF version

King of Prussia, PA, 08 February, 2012 – Greenphire, the leading provider of payment technologies for the clinical trials industry, today announced that it has been chosen as one of three finalists for the Philadelphia Alliance for Capital and Technologies (PACT) Enterprise Award in the Technology Startup division.

(PressReleasePoint) - Selection for the award was based on Greenphire’s established success in delivering an innovative product to meet a significant market need, potential for significant growth, managerial ability and record of achieving success, and demonstration of success via significant business milestones such as raising capital and achieving revenue growth.
Greenphire and the other Enterprise Award finalist companies will be honored at the 19^th Annual Enterprise Awards gala of 1,200 prominent business leaders on Thursday, May 3, 2012, at the Hilton Philadelphia City Line.

The Enterprise Award finalists were selected from among hundreds of Greater Philadelphia area technology and life sciences companies nominated by entrepreneurs, investors, bankers, journalists, and industry insiders. Past winners include Siemens Healthcare, BioClinica, Shire Pharmaceuticals, and other leaders in the pharmaceutical and clinical trials industry. The PACT board of independent judges conducted a rigorous two-month selection process to determine the finalists, and will continue to evaluate each finalist’s ongoing performance in order to choose the winners.

“This year the number of applicants and, more importantly, the quality of applicants was at an all-time high,” said Charles Robins, managing director at Fairmount Partners and lead judge for the Enterprise Awards. “We have been through an era where companies have had to live on less capital, and what’s happened is we have a new generation of companies and of entrepreneurs who are growing successfully. It sets a very optimistic base for our future, and all of the judges this year felt that all of the companies being honored as finalists are superb choices.”

Greenphire CEO Sam Whitaker expressed the company’s enthusiasm with the selection, saying “The Enterprise Award is the top regional recognition in our industry and we are thrilled to be considered for this prestigious honor. Greenphire has seen rapid expansion over the past year and this selection comes at the perfect time for us to continue establishing ourselves as the leaders in clinical payments both here in the greater Philadelphia region and across the clinical trials industry.”
A full list of this year’s Enterprise Award finalists and past winners can be found on the PACT website at http://pact.gpcc.com/

About Greenphire
Greenphire’s clinical payment and communication solutions take a patient-centric and site-centric approach to driving data integrity and data completeness for sponsor, CRO, research university, and clinical research site clients. Greenphire’s web-based technologies are designed to improve the clinical experience for patients and sites, drive positive patient behavior, increase patient retention and compliance, and significantly reduce site and study team administration associated with patient payments and communication. Greenphire’s strategy is driven by the philosophy that empowered, satisfied patients and sites will deliver more consistent and better quality clinical data, which will in turn benefit both site coordinators and study teams. Learn more about Greenphire’s innovative clinical solutions at www.greenphire.com.

For further information on Greenphire and its innovative solutions please email: sales@greenphire.com, call +1 215-609-4640 or visit www.greenphire.com.

For further press information please contact Celine Goodier, The Scott Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire CW4 8AA, United Kingdom. Phone +44 1477 539539, Fax +44 1477 539540, Email greenphire@scottpr.com